Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vaginal Atrophy: later-stage trial registry
4 of 10 indexed Vaginal Atrophy trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 4 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Vaginal Atrophy: 10 US clinical trials tracked, 4 recruiting.
Vaginal Atrophy is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Stratpharma, running 2 of these trials.
Enrollment posture brief
Registry condition vaginal-atrophy
OPEN 4 | RECR 40% | LATE 6 | EARLY 0 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Myeloid Leukemia (AML) (40% recruiting · 30 trials)
Vaginal Atrophy lists 4 open slots (40% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vaginal Atrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vaginal Atrophy is recruiting below its size-band peers.
4 of 10 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Vaginal Atrophy research.
Stratpharma accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Vaginal Atrophy enrolment sits around 100 participants.
Median target enrolment is 100 among the 10 trials that report a genuine target (sentinel values excluded). 5 of those (50%) plan for fewer than 100 participants.
-
Vaginal Atrophy research is mostly interventional.
10 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Stratpharma
NCT05953090
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
Maimonides Medical Center
NCT04807894
Postpartum Vaginal Estrogen for Breastfeeding Patients
University Hospitals Cleveland Medical Center
NCT05457972
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
Stratpharma
NCT07346287
PRP Injections for Genitourinary Syndrome of Menopause
Medstar Health Research Institute
NCT06028009
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause
Wyeth is now a wholly owned subsidiary of Pfizer
NCT00238732
Topical DHEA Against Vaginal Atrophy
EndoCeutics
NCT01846442
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
Sciton
NCT03178825
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
University of Alabama at Birmingham
NCT03996603
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
Alma Lasers
NCT02747641
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Vaginal Atrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vaginal Atrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vaginal Atrophy page
10 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Vaginal Atrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Stratpharma sponsors the most Vaginal Atrophy trials on record, review their full trial history before evaluating a specific study. See Stratpharma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vaginal Atrophy condition card totals 10 registered trials; most-linked intervention Pixel CO2 Laser System; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.